Genetic cause of atrial fibrillation

Scientists at Ben Gurion University have found that common (mostly night-time) atrial fibrillation (heart rhythm problems) is caused by a mutation in a gene (KCND2). They are now developing an anti-arrhythmia medication, based on their findings. It could save 200,000 lives each year.

NATO recognizes Israel as key medical assistance partner

NATO has recognized the Israeli Navy as a key medical-assistance partner in the Mediterranean following a drill held last month practicing emergency evacuations of personnel. “Crystal Sea 2020” involved the United Kingdom, Greece, Romania and Bulgaria.

Sheba hospital – the Cyprus connection

Several newsletter articles highlight the humanitarian work done at Israel’s Sheba medical center in Tel Hashomer on behalf of citizens of Cyprus. Another example here is when a Cypriot police officer was shot in the spine and airlifted to Sheba for successful treatment.

The first medical school in Samaria is open

Seventy students were accepted into the first class of the Dr. Miriam and Sheldon G. Adelson School of Medicine at Ariel University. It is the sixth medical school in Israel and the first in Samaria. US Ambassador David Friedman gave the traditional Hebrew ‘Shecheyanu’ blessing.

Relieving pain for pancreatic cancer patients

Doctors at Israel’s Sheba Medical Center have managed to substantially reduce the pain suffered by cancer patients. Radiation is targeted at a nerve behind the pancreas. After 3 weeks, the patient is strong enough to embark on further cancer treatment.

Detecting and treating prostate cancer

For Men’s Health Awareness Month, here are 7 Israeli startups focused on detection and treatment of prostate cancer. Two have not been reported here previously. They are Keren Medical’s anastomosis device for bladder operations; and UC-Care’s ultrasound tumor tracking tools.

Turning mosquitos against themselves

As reported previously there are several Israeli innovations developed to help reduce numbers of disease infecting mosquitos. Now Ben Gurion University scientists have discovered and activated bacteria in the male mosquito that is poisonous only to mosquito larvae.

US approval for H. pylori treatment

The US FDA has given approval for Israel’s Redhill Biopharma to market its RHB-105 (Talicia) treatment for the treatment of Helicobacter pylori (H. pylori). It follows successful Phase 3 trials, as reported previously. H. pylori affects some 2 million US patients.

Leukemia treatment extends to solid tumors

Tel Aviv University scientists have engineered the successful Israel-invented CAR-T cell therapy to also treat other cancers. They discovered a subset of immune system T cells (known as CD4+ T cells) will attract antibodies on solid tumors and destroy them.

New Israeli record for blood donations

Israelis donated 1,567units of blood in one day at the Magen David Adom station at the Samaria Regional Division. They broke the previous Israeli record of 740 units in a 2014 Tel Aviv session. Donors included residents and soldiers from the IDF’s Samaria Division.